To assess the role of GSK3β phosphorylation in TBX21-mediated inhibition of CRC migration, the GSK3β phosphorylation activator LiCl was used to increase GSK3β phosphorylation. The gene discussed is GSK3B; the disease is colorectal carcinoma.